![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 27, 25230-25235, July 6, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The processing of secretory preproteins by signal
peptidases (SPases) is essential for cell viability. As
previously shown for Bacillus subtilis, only certain SPases
of organisms containing multiple paralogous SPases are essential. This
allows a distinction between SPases that are of major and minor
importance for cell viability. Notably, the functional
difference between major and minor SPases is not reflected clearly in
sequence alignments. Here, we have successfully used molecular
phylogeny to predict major and minor SPases. The results were verified
with SPases from various bacilli. As predicted, the latter enzymes
behaved as major or minor SPases when expressed in B. subtilis. Strikingly, molecular modeling indicated that the
active site geometry is not a critical parameter for the classification
of major and minor Bacillus SPases. Even though the
substrate binding site of the minor SPase SipV is smaller than that of
other known SPases, SipV could be converted into a major SPase without
changing this site. Instead, replacement of amino-terminal residues of
SipV with corresponding residues of the major SPase SipS was sufficient
for conversion of SipV into a major SPase. This suggests that
differences between major and minor SPases are based on activities
other than substrate cleavage site selection.
Distinction between Major and Minor Bacillus Signal
Peptidases Based on Phylogenetic and Structural Criteria*
§,
§,
,
, and
Department of Genetics, Groningen
Biomolecular Sciences and Biotechnology Institute, University of
Groningen, Kerklaan 30, 9751 NN Haren, The Netherlands, and the
¶ Department of Pharmaceutical Biology, University of
Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The
Netherlands
*
This work was supported by the Dutch Ministry of Economic
Affairs through Associatie Biologische Onderzoeksscholen Nederland (to
M. L. v.R.), Stichting Levenswetenschappen Grant 805-33.605 (to
J. D. H. J), and European Union Grants QLK3-CT-1999-00413 and
QLK3-CT-1999-00917 (to S. B, J. D. H. J., J. Y. D., and
J. M. v.D.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
31-50-363-3079; Fax: 31-50-363-2348; E-mail:
J.M.VAN.DIJL@FARM.RUG.NL.
This article has been cited by other articles:
![]() |
M. J. J. B. Sibbald, A. K. Ziebandt, S. Engelmann, M. Hecker, A. de Jong, H. J. M. Harmsen, G. C. Raangs, I. Stokroos, J. P. Arends, J. Y. F. Dubois, et al. Mapping the Pathways to Staphylococcal Pathogenesis by Comparative Secretomics Microbiol. Mol. Biol. Rev., September 1, 2006; 70(3): 755 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Raynaud and A. Charbit Regulation of expression of type I signal peptidases in Listeria monocytogenes Microbiology, November 1, 2005; 151(11): 3769 - 3776. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stephenson, C. Mueller, M. Jiang, and M. Perego Molecular Analysis of Phr Peptide Processing in Bacillus subtilis J. Bacteriol., August 15, 2003; 185(16): 4861 - 4871. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Venema, H. Tjalsma, J. M. van Dijl, A. de Jong, K. Leenhouts, G. Buist, and G. Venema Active Lipoprotein Precursors in the Gram-positive Eubacterium Lactococcus lactis J. Biol. Chem., April 18, 2003; 278(17): 14739 - 14746. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |